Our Projects

Unitaid's projects are the life blood of our business. Our funding allows innovative medications, diagnostics tools and public-health techniques to be introduced in developing countries speedily and at an affordable price.

Whether they address HIV/AIDS, tuberculosis, malaria or hepatitis C, all our grants have one thing in common: they bring the best that science has to offer and put it to work for those in need. Browse our projects below to find out more about the transformative work that Unitaid grants are funding.

Filters / Search

Grant focus
Promote self-testing to increase the number of people who know their HIV status

Lead Grantee
Population Service International (PSI)

Status
Active

Amount
US $23,661,000

Disease
HIV

Stimulating and shaping the market for HIV self-testing in Africa (STAR)

View More

Grant focus
Making correctly dosed, properly formulated, high-quality TB medicines for children widely available

Lead Grantee
TB Alliance

Status
Closed

Amount
US $16,606,000

Disease
Tuberculosis

Addressing neglected childhood tuberculosis (STEP-TB)

View More

Grant focus
Negotiate licences to enable the manufacture of low-cost, high-quality HIV, hepatitis C and tuberculosis medicines for developing countries

Lead Grantee
Medicines Patent Pool

Status
Active

Amount
US $60,367,000

Disease
Hepatitis C, HIV, Tuberculosis

The Medicines Patent Pool

View More

Grant focus
Making artesunate more widely available to treat children with severe malaria

Lead Grantee
Medicines for Malaria Venture (MMV)

Status
Active

Amount
US $34,000,000

Disease
Malaria

Better treatment for severe malaria

View More

Grant focus
Provide appropriate-strength paediatric TB drugs and develop new formulations for children under five years old

Lead Grantee
Global Drug Facility (GDF), Stop TB Partnership

Status
Closed

Amount
US $13,144,000

Disease
Tuberculosis

Paediatric tuberculosis project

View More

Grant focus
Protect 25 million children from seasonal malaria in Africa’s Sahel region

Lead Grantee
Malaria Consortium

Status
Active

Amount
US $67,435,000

Disease
Malaria

Seasonal malaria chemoprevention for children in the Sahel

View More

Grant focus
Develop a better formulation of a key component of paediatric ARV regimens and promote in-country adoption of “4-in-1” fixed-dose formulations

Lead Grantee
Drugs for Neglected Diseases Initiative (DNDi)

Status
Active

Amount
US $17,335,000

Disease
HIV

Better HIV treatment for infants and young children

View More

Grant focus
Reduce transmission and mortality of multidrug-resistant TB (MDR-TB) and strengthen the market for drugs to treat it

Lead Grantee
Partners in Health (PIH)

Status
Active

Amount
US $60,370,000

Disease
Tuberculosis

Expand new drug markets for TB (End-TB)

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.